Rangaramanujam Kannan - Search Results

Year	Number of Results
2003	2
2004	2
2005	2
2006	2
2007	1
2008	3
2009	5
2010	11
2011	6
2012	4
2013	9
2014	3
2015	9
2016	8
2017	10
2018	12
2019	2
2020	13
2021	8

1

Editorial.

Hanes J, Ensign L, Kannan R, Suk JS. Hanes J, et al. Among authors: kannan r. J Control Release. 2015 Dec 10;219:1. doi: 10.1016/j.jconrel.2015.10.057. J Control Release. 2015. PMID: 26590704 No abstract available.

2

Targeting Mitochondrial Dysfunction and Oxidative Stress in Activated Microglia using Dendrimer-Based Therapeutics.

Sharma A, Liaw K, Sharma R, Zhang Z, Kannan S, Kannan RM. Sharma A, et al. Among authors: kannan rm. Theranostics. 2018 Nov 5;8(20):5529-5547. doi: 10.7150/thno.29039. eCollection 2018. Theranostics. 2018. PMID: 30555562 Free PMC article.

3

Nanotechnology enabled regenerative medicine for neurological disorders.

Lowe TL, Agrahari V, Kannan RM, Kannan S. Lowe TL, et al. Among authors: kannan rm. Adv Drug Deliv Rev. 2019 Aug;148:1-2. doi: 10.1016/j.addr.2019.11.006. Adv Drug Deliv Rev. 2019. PMID: 31787167 Free PMC article. No abstract available.

4

Nanomedicine in cerebral palsy.

Balakrishnan B, Nance E, Johnston MV, Kannan R, Kannan S. Balakrishnan B, et al. Among authors: kannan r. Int J Nanomedicine. 2013;8:4183-95. doi: 10.2147/IJN.S35979. Epub 2013 Nov 1. Int J Nanomedicine. 2013. PMID: 24204146 Free PMC article. Review.

5

Emerging nanomedicine approaches in obstetrics.

Kannan RM, Kannan S. Kannan RM, et al. Am J Obstet Gynecol. 2017 Mar;216(3):201-203. doi: 10.1016/j.ajog.2017.01.038. Am J Obstet Gynecol. 2017. PMID: 28249659 No abstract available.

6

Nanotechnology approaches for ocular drug delivery.

Xu Q, Kambhampati SP, Kannan RM. Xu Q, et al. Among authors: kannan rm. Middle East Afr J Ophthalmol. 2013 Jan-Mar;20(1):26-37. doi: 10.4103/0974-9233.106384. Middle East Afr J Ophthalmol. 2013. PMID: 23580849 Free PMC article. Review.

7

Dendrimer nanoparticles for ocular drug delivery.

Kambhampati SP, Kannan RM. Kambhampati SP, et al. Among authors: kannan rm. J Ocul Pharmacol Ther. 2013 Mar;29(2):151-65. doi: 10.1089/jop.2012.0232. Epub 2013 Feb 14. J Ocul Pharmacol Ther. 2013. PMID: 23410062 Review.

8

Dense hydroxyl polyethylene glycol dendrimer targets activated glia in multiple CNS disorders.

Sharma A, Sharma R, Zhang Z, Liaw K, Kambhampati SP, Porterfield JE, Lin KC, DeRidder LB, Kannan S, Kannan RM. Sharma A, et al. Among authors: kannan rm. Sci Adv. 2020 Jan 22;6(4):eaay8514. doi: 10.1126/sciadv.aay8514. eCollection 2020 Jan. Sci Adv. 2020. PMID: 32010790 Free PMC article.

9

Dendrimer-Mediated Targeted Delivery of Rapamycin to Tumor-Associated Macrophages Improves Systemic Treatment of Glioblastoma.

Sharma A, Liaw K, Sharma R, Spriggs T, Appiani La Rosa S, Kannan S, Kannan RM. Sharma A, et al. Among authors: kannan rm. Biomacromolecules. 2020 Dec 14;21(12):5148-5161. doi: 10.1021/acs.biomac.0c01270. Epub 2020 Oct 28. Biomacromolecules. 2020. PMID: 33112134

10

NMDA Receptor Antagonism for Neuroprotection in a Canine Model of Hypothermic Circulatory Arrest.

Giuliano K, Etchill E, Zhou X, Lui C, Suarez-Pierre A, Sharma R, Wilson MA, Blue ME, Troncoso JC, Kannan S, Johnston MV, Sharma A, Kannan RM, Baumgartner WA, Lawton J. Giuliano K, et al. Among authors: kannan rm. J Surg Res. 2021 Apr;260:177-189. doi: 10.1016/j.jss.2020.11.075. Epub 2020 Dec 18. J Surg Res. 2021. PMID: 33348169

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results